Stock Events

Stock Events

Cartesian Therapeutics (RNAC) Q2 2025 Earnings

8MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-1.13

-0.57

-0.02

0.54

Details

Expected EPS

-0.70125

Actual EPS

-0.68

Surprise EPS

0.02

Surprise Percent

+3.03%

Description

Cartesian Therapeutics (RNAC) has reported earnings of -0.68 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.